| abstract |
An antibody specifically binding to a GARP/TGFβ1 compound or an antigen-binding fragment thereof, a multispecific antigen-binding molecule and a chimeric antigen receptor containing same, an immune effector cell expressing the chimeric antigen receptor, and a pharmaceutical composition prepared from the antibody, a pharmaceutical use of the antibody, and a use of the antibody in treating a disease. The present invention further relates to an encoding nucleic acid, a vector containing the nucleic acid, a host cell containing the nucleic acid or vector, and a method for preparing and purifying the antibody. |